Try our beta test site

Efficacy and Safety of Ambrisentan in Children 8-18yrs

This study has suspended participant recruitment.
(Ongoing juvenile rat toxicology studies.)
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01332331
First received: March 24, 2011
Last updated: March 21, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: November 2018
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)